On April 3, 2013, Vantage entered into an agreement with Neuland Laboratories Limited to purchase technology to manufacture various active pharmaceutical ingredients. The future cost of this contract is not specifically identified at this time. However, the contract calls for a cost of between $250,000 and $400,000 per active pharmaceutical ingredient technology purchased.
These guys have a ton of projects in play. This should easily revisit silver with this SS.
$VNTH
J
Market Data 
Markets 
AI
